Journalism of Courage
Cipla
Follow on:
Cipla Limited: A Global Pharmaceutical Giant Cipla Limited, headquartered in Mumbai, stands as a prominent multinational pharmaceutical company with a global reach. Its core focus lies in developing and manufacturing medications targeting a wide spectrum of diseases, including respiratory ailments, ...
- Company type Public
- Industry Pharmaceuticals
- Founded 1935 (90 years ago) (1935)
- Founders Khwaja Abdul Hamied
- Headquarters Mumbai, Maharashtra, India
- Area served Worldwide
- Revenue ₹25,455 crore (US$2.9 billion) (FY24)
- Net income ₹4,106 crore (US$470 million) (FY24)
- Number of employees 22,036
- Subsidiaries Invagen Pharmaceuticals
- Website www.cipla.com
Related Other Pages:
Cipla history
Last Updated : 25/03/25, 11:12 PM
Cipla: A Legacy of Pharmaceutical Innovation Established in Mumbai in 1935 as Chemical, Industrial & Pharmaceutical Laboratories, Cipla, under the stewardship of Khwaja Abdul Hamied, laid the foundation for its enduring legacy. Following Hamied's death in 1972, his son Yusuf Hamied, a Cambridge-...
CIPLA NEWS
Cipla infringing Roche’s patent in lung cancer drug, says Delhi HC
November 28, 2015 1:36 am
Delhi HC refused to issue any injunction against Cipla restraining it from manufacturing the medicine, after observing that the life of the patent granted to Roche was ending in March 2016.
Cipla enhances US push with 2 buys for $550 mn
September 05, 2015 3:07 am
Cipla will as a result of these acquisitions gain multiple products in the areas of anti-infectives, diabetes and central nervous system disorders.
Cipla’s gain in German firm’s drug patent loss
March 11, 2015 1:50 am
Cipla had challenged the patent, arguing that Tiotropium bromide monohydrate, sold under the brand name Spiriva.
Cipla challenges HC order against manufacturing generic drug
January 14, 2015 8:40 am
Cipla had last year started manufacturing and selling a generic drug using the Indacaterol maleate salt.
HC bars Cipla from selling drug containing Indacaterol
January 10, 2015 2:24 am
The firm has been selling the drug in India under the trademark ‘Onbrez’ through Lupin since 2010.
Judgment reserved on Novartis-Cipla patent dispute
December 17, 2014 1:06 am
Novartis has also sought damages and payment for infringing the patented pharmaceutical product.
Innovation that includes
April 26, 2014 12:20 am
The pharmaceutical industry needs to shed its archaic blockbuster model.
India Inc has time till Oct 1 to bring women on board
February 18, 2014 3:33 am
A look at the 30 bluechip companies that form the benchmark Sensex at the Bombay Stock Exchange reveals that over one third or 11 companies including Reliance Industries, TCS, ONGC and L&T do not have a woman director.
BSE Sensex drops 42 pts to over week's low ahead of RBI policy review meet
October 25, 2013 4:57 pm
The BSE Sensex fell 42 points amid profit booking today.
BSE Sensex continues retreat from 3-year closing high,Gail India,Cipla shares top gainers
October 23, 2013 4:59 pm
BSE Sensex falls 0.47 pct,NSE Nifty ends 0.39 pct lower,FIIs remain net buyers of Indian shares.
